Consolidated Portfolio Review Corp »

Pfizer shares owned by Consolidated Portfolio Review Corp

Quarter-by-quarter ownership of Pfizer (PFE) shares owned by Consolidated Portfolio Review Corp from 13F filings

Historical chart of Consolidated Portfolio Review Corp investment in Pfizer

Tip: Access up to 7 years of quarterly data

All positions including Pfizer held by Consolidated Portfolio Review Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pfizer by Consolidated Portfolio Review Corp

Quarter filed Position value Share count Share price at filing
2023-12-31 $316k 11k 28.79
2023-09-30 $439k 13k 33.17
2023-06-30 $502k 14k 36.68
2023-03-31 $535k 13k 40.80

More positions owned by Consolidated Portfolio Review Corp

Vanguard Bd Index Fds Intermed Term (BIV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Growth Etf (VUG)
Vanguard World Health Car Etf (VHT)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Equal Weight Us (GSEW)
Vanguard Index Fds Value Etf (VTV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
Vanguard World Consum Stp Etf (VDC)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Amazon (AMZN)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
NVIDIA Corporation (NVDA)

View all positions for Consolidated Portfolio Review Corp

Top funds holding Pfizer

Vanguard Group
Wellington Management Company
Charles Schwab Investment Management
Norges Bank Investment Management
Massachusetts Financial Services
State Farm Mutual Automobile Insurance Company
Bank of America Corporation
Legal & General Group
Amundi
Jpmorgan Chase & Co
Bank of New York Mellon
Dimensional Fund Advisors
Citadel Advisors
Deutsche Bank Aktiengesellschaft
T. Rowe Price Associates

View all funds holding Pfizer